In clinical studies, 87% of patients experienced distinct improvements in skin areas affected by psoriasis and psoriatic lesions.
Significant improvements in itchy and scaly skin were reported by study participants after just four weeks of use.
The Zymbilan® Dual Approach addresses psoriasis symptoms by helping to restore skin turnover and repair the disturbed skin barrier.
Psoriasis symptoms are addresseed externally with RetileX-A®-PRO, the active ingredient in Zymbilan® cream, and internally with Vercilex®-F, the bioactive ingredient in Zymbilan® tablets that provides Proteoglycan Replacement Therapy.
Together, this dual therapeutic approach helps repair the skin barrier and rebalances skin matrix components to address the symptoms of psoriasis and other chronic skin disorders, including:
Zymbilan® is based on more than 30 years of clinical research into Proteoglycan Replacement Therapy and retinoid-based skin treatment. Zymbilan® is a natural, drug-free therapy and recognised as such by health authorities on all continents, including the FDA, Anvisa, Cofepris, and EFSA (European Food Safety Authority).
Zymbilan® is available in pharmacies and through select dermatologist clinics without a prescription.